Affle 3i Limited Grants 65,880 Stock Options to Employees Under ESOS 2021

Affle 3i Limited (formerly known as Affle (India) Limited) has informed the stock exchanges of a fresh grant of stock options to its eligible employees under the Affle (India) Limited Employee Stock Option Scheme – 2021 ("Scheme"), in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The grant was made effective May 7, 2026, and the disclosure was submitted by Company Secretary & Compliance Officer Parmita Choudhury.

Stock Option Grant Details

The company has granted a total of 65,880 options to eligible employees, covering an equivalent number of equity shares. The Scheme is compliant with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The key parameters of the grant are summarised in the table below:

Parameter: Details Number of Options Granted: 65,880 Effective Grant Date: May 7, 2026 Equity Shares Covered: 65,880 equity shares of face value Rs. 2 each Exercise Price: Closing market price on NSE on May 6, 2026 Exercise Period: 1 year from the date of vesting SEBI Regulation Compliance: SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

Vesting Schedule

The options will vest in a graded manner over a period of 48 months from the date of grant, subject to the terms and conditions specified in the Scheme. The vesting structure is as follows:

25% of the options granted will vest at 12 months from the date of grant

25% of the options granted will vest at 24 months from the date of grant

25% of the options granted will vest at 36 months from the date of grant

25% of the options granted will vest at 48 months from the date of grant

Each tranche, once vested, may be exercised within 1 year from the respective date of vesting.

Regulatory Disclosure

The company confirmed that no options have been exercised, lapsed, or cancelled as part of this grant, and no variation to the terms of the options has been made. There are no subsequent changes or cancellations to report at this stage. The disclosure was made in accordance with applicable SEBI listing regulations and the Master Circular issued by SEBI, ensuring transparency with shareholders and market participants.

Affle 3i Limited (formerly known as Affle (India) Limited) has announced the scheduling of its Earnings Conference Call for investors and analysts, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The call is set for Monday, May 11, 2026 at 10:00 AM IST and will cover results and key developments for the fourth quarter and financial year ended March 31, 2026.

Conference Call Details

The earnings call will feature senior members of the company's leadership team. The following key details summarise the event:

Parameter: Details Date: Monday, May 11, 2026 Time: 10:00 AM IST Purpose: Q4 & 12M FY2026 Results Discussion Period Covered: Fourth quarter and financial year ended March 31, 2026

Management Representation

The call will be represented by the following senior executives:

Name: Designation: Mr. Anuj Khanna Sohum Chairperson, MD & CEO Mr. Kapil Bhutani Chief Financial and Operations Officer

Dial-In and Access Information

Investors and analysts can participate in the call through multiple access options. Pre-registration via the DiamondPass link is available to avoid waiting queues. For those joining via dial-in, the following numbers have been provided:

Access Type: Dial-In Number: Universal Access +91 22 6280 1148 Universal Access +91 22 7115 8049 Hong Kong (Toll-Free) 800 964 448 Japan (Toll-Free) 005 3116 1110 Singapore (Toll-Free) 800 101 2045 UK (Toll-Free) 0 808 101 1573 USA (Toll-Free) 1 866 746 2133

Investor Relations Contact

For further information regarding the earnings call, stakeholders may reach out to the following contacts:

Ashwin Mehta, Head of Equity Research, Ambit Capital Private Limited — ashwin.mehta@ambit.co

Harshit Talesara, Investor Relations, Affle 3i Limited — investor.relations@affle.com

For investor grievance and compliance-related queries, stakeholders may contact compliance@affle.com . The earnings conference call invite, along with dial-in details, will also be made available on the company's official website at www.affle.com . The intimation was submitted by Parmita Choudhury, Company Secretary & Compliance Officer, on behalf of Affle 3i Limited.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.